Cleared Traditional

K790252 - ANTI-NATIVE DEOXYRIB-ONUCLEIC ACID ANTI

K790252 is the FDA 510(k) clearance for ANTI-NATIVE DEOXYRIB-ONUCLEIC ACID ANTI by Meloy Laboratories, Inc.. It is a Class 2 Immunology device (product code DHN) cleared through the Traditional 510(k) pathway after a 37-day FDA review.

K790252 · Meloy Laboratories, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1979
Decision
37d
Days
Class 2
Risk

K790252 is an FDA 510(k) clearance for the ANTI-NATIVE DEOXYRIB-ONUCLEIC ACID ANTI. Classified as Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control (product code DHN), Class II - Special Controls.

Submitted by Meloy Laboratories, Inc. (Mchenry, US). The FDA issued a Cleared decision on March 15, 1979 after a review of 37 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5100 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Meloy Laboratories, Inc. devices

Submission Details

510(k) Number K790252 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 06, 1979
Decision Date March 15, 1979
Days to Decision 37 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 104d · This submission: 37d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control

All 54
Devices cleared under the same product code (DHN) and FDA review panel - the closest regulatory comparables to K790252.
ANATON
K801046 · Armkel, LLC · May 1980
LAB-TEK ANA TEST KIT
K792184 · Miles Laboratories, Inc. · Nov 1979
AUTOANTIBODY REAGENTS, AFT SYSTEM II
K790280 · Calbiochem-Behring Corp. · Apr 1979
TEST KIT, IIF-ANA
K782048 · Medica Corp. · Jan 1979
FLUORESCENT ANTI-NATIVE DNA TEST
K780899 · Kallestad Laboratories, Inc. · Sep 1978
TEST SYS. FOR NDNA ANTIBODY DETERM.
K780178 · Zeus Scientific, Inc. · Feb 1978